PROPHYLIX PHARMA HOLDING AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−156k kr).
PROPHYLIX PHARMA HOLDING AS is registered as a limited company in Tromsø, Troms with organisation number 920056245. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2017. Registered share capital is NOK 609,000, divided into 609130 shares. The company's stated purpose is: “Å investere i aksjer og i andre selskaper og alt som står i forbindelse med dette.”.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns PROPHYLIX PHARMA HOLDING AS?
PROPHYLIX PHARMA HOLDING AS has 19 registered shareholders:
- NORINNOVA INVEST AS 31.4%
- SARSIA SEED AS 19.1%
- TROND MOHN FORSKNINGSSTIFTELSE 15.5%
- NORINNOVA AS 8.9%
- UNIVERSITETSSYKEHUSET NORD-NORGE HF 5.7%
- Mette Kjær 4.7%
- KRAKR AS 2.0%
- Bjørn Ragnar Skogen 2.0%
- BO JESPER HANSEN 1.8%
- Rolf Jorde 1.6%
- Anne Husebekk 1.5%
- Jens Kjeldsen-Kragh 1.2%
- CAERUS CAPITAL AS 1.1%
- INVEN2 AS 1.1%
- SØREN WEISS DAHL 0.9%
- Anne Keller 0.7%
- Magnus Seppola 0.4%
- JONAS LUNDAHL 0.2%
- PHARMAPATENT AS 0.1%
Which companies does PROPHYLIX PHARMA HOLDING AS own?
PROPHYLIX PHARMA HOLDING AS holds a stake in 1 company:
- PROPHYLIX AS 100.0%
Frequently asked questions about PROPHYLIX PHARMA HOLDING AS
Who owns PROPHYLIX PHARMA HOLDING AS?
NORINNOVA INVEST AS is the largest registered owner, with 31.4%.
Where is PROPHYLIX PHARMA HOLDING AS based?
PROPHYLIX PHARMA HOLDING AS has its business address in Tromsø.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.